euportal twitter euportal facebook

Research project support

COVID - 19 2

11.9.2020 – The Commission announced today that it will support with €4 million a new research project, SUPPORT-E, that will coordinate efforts to determine if COVID-19 convalescent plasma transfusion – using plasma from patients who recovered from the disease – is an effective and safe treatment. The funding is part of the Commission’s €1 billion [...]

Read more

Remdesivir – cure for COVID -19

COVID - 19 2

29.7.2020 – Yesterday, the European Commission has signed a contract with the pharmaceutical company Gilead to secure treatment doses of Veklury, the brand name for Remdesivir. Veklury was the first medicine authorised at EU level for treatment of COVID-19. As from early August onwards, and in order to meet immediate needs, batches of Veklury will [...]

Read more